Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours. [electronic resource]
Producer: 20130418Description: 447-55 p. digitalISSN:- 1432-1335
- Adult
- Aged
- Antibodies, Monoclonal -- administration & dosage
- Cohort Studies
- Cytokines -- administration & dosage
- Disease Progression
- Dose-Response Relationship, Drug
- Female
- Humans
- Male
- Middle Aged
- Molecular Targeted Therapy -- methods
- Neoplasms -- drug therapy
- Recombinant Fusion Proteins -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.